NOV 17, 202657 MINS READ
Isopropyl Palmitate is synthesized via esterification of isopropyl alcohol with palmitic acid (hexadecanoic acid), yielding a branched-chain fatty acid ester with the chemical structure CH₃(CH₂)₁₄COOCH(CH₃)₂2. This compound exhibits a molecular weight of 298.5 g/mol, a melting point range of 11–14°C, and a boiling point of approximately 190°C at 3 mmHg2. Its lipophilic nature (log P ≈ 7.6) facilitates rapid penetration through lipid membranes, which is critical for both its functional efficacy and toxicological behavior3.
Key physicochemical parameters influencing toxicity include:
The structural similarity between Isopropyl Palmitate and Isopropyl Myristate (differing by two methylene units in the fatty acid chain) results in comparable toxicological profiles, though subtle differences in dermal penetration rates and metabolic kinetics have been documented12.
Acute toxicity studies in rodent models demonstrate that Isopropyl Palmitate exhibits remarkably low systemic toxicity. Oral LD₅₀ values in rats exceed 10,000 mg/kg body weight, classifying IPP as "practically non-toxic" under the Globally Harmonized System (GHS) Category 52. Dermal LD₅₀ values in rabbits similarly exceed 5,000 mg/kg, with no evidence of significant percutaneous absorption leading to systemic effects3.
Comparative acute toxicity data for isopropyl-containing esters:
Due to its low vapor pressure, inhalation exposure to Isopropyl Palmitate vapor is negligible under ambient conditions2. Aerosol exposure studies (relevant to spray formulations) in rats at concentrations up to 5 mg/L air for 4 hours produced no mortality or respiratory distress, though mild, transient nasal irritation was observed at the highest dose1. This contrasts sharply with volatile halogenated solvents such as 2-bromopropane, which exhibit significant neurotoxicity and reproductive toxicity upon inhalation at concentrations >100 ppm4.
Draize rabbit eye irritation tests classify Isopropyl Palmitate as "minimally irritating," with transient conjunctival redness resolving within 24–48 hours and no corneal opacity or iritis3. Dermal irritation scores (Primary Irritation Index) are consistently <2.0, indicating non-irritating to mildly irritating classification23. Repeated insult patch testing in human volunteers (n=50) showed no evidence of sensitization or cumulative irritation after 10 consecutive daily applications of 0.5 mL IPP under occlusive conditions3.
Subchronic (90-day) oral gavage studies in rats administered Isopropyl Palmitate at doses of 100, 500, and 2,000 mg/kg/day revealed no treatment-related adverse effects on body weight gain, hematological parameters, clinical chemistry, or organ weights2. Histopathological examination of liver, kidney, spleen, and reproductive organs showed no compound-related lesions at any dose level, establishing a No-Observed-Adverse-Effect Level (NOAEL) of ≥2,000 mg/kg/day2.
Dermal application studies (28-day) in rabbits receiving 1,000 mg/kg/day IPP (6 hours/day, 5 days/week) demonstrated:
Isopropyl Palmitate has been extensively evaluated for genotoxic potential across multiple assay systems:
These data collectively support the conclusion that Isopropyl Palmitate is non-genotoxic and poses negligible mutagenic risk under realistic exposure scenarios23.
Upon dermal or oral absorption, Isopropyl Palmitate undergoes rapid enzymatic hydrolysis by esterases (primarily carboxylesterases in liver and skin) to yield isopropyl alcohol and palmitic acid23. Both metabolites are endogenous or readily metabolized:
Pharmacokinetic studies in rats using radiolabeled ¹⁴C-IPP demonstrated >95% elimination within 72 hours, primarily via CO₂ exhalation (60–70%) and urinary excretion of water-soluble metabolites (20–30%)2. Tissue accumulation was negligible, with <1% of administered dose detected in adipose tissue at 168 hours post-dosing2.
The metabolic pathway of Isopropyl Palmitate closely parallels that of Isopropyl Myristate, though the longer carbon chain of IPP results in slightly slower hydrolysis kinetics (t₁/₂ hydrolysis ≈ 45 minutes for IPP vs. 30 minutes for Isopropyl Myristate in rat liver microsomes)12. This difference has minimal toxicological significance, as both esters are efficiently cleared and do not form reactive intermediates2.
In contrast, halogenated isopropyl compounds such as 2-bromopropane undergo cytochrome P450-mediated oxidation to reactive epoxides, which covalently bind to DNA and proteins, accounting for their reproductive and neurotoxic effects4. The absence of halogen substituents in Isopropyl Palmitate eliminates this toxicity mechanism24.
Isopropyl Palmitate and Isopropyl Myristate function as synergists in pesticidal compositions containing plant essential oils (e.g., 2-phenethyl propionate, wintergreen oil, eugenol), enhancing contact toxicity against arthropod pests while maintaining low mammalian toxicity12. Formulations containing 66–86.5% Isopropyl Myristate or Isopropyl Palmitate achieved >90% mortality in German cockroaches (Blattella germanica) and carpenter ants (Camponotus spp.) within 30 minutes of topical application1.
Mechanistic studies suggest that these esters disrupt the lipid bilayer of insect cuticles, facilitating penetration of active botanical compounds12. Importantly, mammalian skin exhibits lower permeability to these formulations due to differences in stratum corneum lipid composition, contributing to selective toxicity1.
Aquatic toxicity studies demonstrate low hazard potential:
The low water solubility and rapid biodegradation (>60% mineralization in 28 days per OECD 301B) minimize environmental persistence and bioaccumulation potential (log Kow = 7.6 suggests high lipophilicity, but rapid metabolism prevents biomagnification)3.
The Cosmetic Ingredient Review Expert Panel re-evaluated Isopropyl Palmitate in 2019, reaffirming its conclusion that IPP is "safe as used in cosmetics" at concentrations up to 20% in leave-on products and 45% in rinse-off formulations3. The U.S. FDA includes Isopropyl Palmitate in its database of Generally Recognized As Safe (GRAS) substances for indirect food contact applications (e.g., packaging coatings) at levels not exceeding 0.5%3.
Under the EU REACH regulation (EC 1907/2006), Isopropyl Palmitate is registered for use in cosmetics, pharmaceuticals, and industrial applications with the following harmonized classifications3:
No specific Occupational Exposure Limits (OELs) have been established for Isopropyl Palmitate due to its low volatility and minimal inhalation hazard23. General good industrial hygiene practices recommend:
Both esters exhibit nearly identical toxicological profiles, with oral LD₅₀ values >10,000 mg/kg and negative genotoxicity results12. The primary difference lies in cosmetic functionality: Isopropyl Myristate provides lighter skin feel and faster absorption, while Isopropyl Palmitate offers superior emolliency and viscosity control3. From a safety perspective, both are interchangeable in formulations without altering risk assessments23.
2-Bromopropane (isopropyl bromide), used historically as a cleaning solvent, demonstrates markedly higher toxicity than Isopropyl Palmitate4:
This stark contrast underscores the importance of functional group chemistry in determining toxicity: the ester linkage in Isopropyl Palmitate confers metabolic lability and low reactivity, whereas the carbon-halogen bond in 2-bromopropane generates toxic intermediates24.
Clinical studies involving 210 volunteers (Fitzpatrick skin types I–VI) assessed the sensitization potential of 10% Isopropyl Palmitate in a petrolatum vehicle3. The study protocol included:
Results demonstrated zero sensitization reactions (0/210 subjects), with only 2.4% exhibiting transient erythema during induction (attributed to occlusion rather than chemical irritation)3. This confirms the non-sensitizing nature of Isopropyl Palmitate under exaggerated exposure conditions3.
3T3 Neutral Red Uptake Phototoxicity Test (OECD TG 432) and human photopatch testing (n=30) showed no phototoxic or photoallergic responses to Isopropyl Palmitate at concentrations up to 50% under simulated solar radiation (UVA: 6 J/cm², UVB: 1.5 J/cm²)3. This is consistent with the absence of chromophoric groups (conjugated double bonds, aromatic rings) in the IPP structure that could absorb UV radiation and generate reactive oxygen species3.
Isopropyl Palmitate serves as a penetration enhancer in transdermal patches and topical pharmaceutical formulations, increasing drug flux across the stratum corneum by 2–5-fold for lipophilic actives (e.g., estradiol, testosterone, fentanyl)3. The mechanism involves reversible disruption of intercellular lipid lamellae, creating transient aqueous pores
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| ECOSMART TECHNOLOGIES INC. | Household and agricultural pest control applications requiring fast-acting contact pesticides with low toxicity to mammals and wildlife, particularly for indoor use against cockroaches and ants. | Botanical Pesticide Formulations with Isopropyl Myristate/Palmitate | Achieved >90% mortality in German cockroaches and carpenter ants within 30 minutes using 66-86.5% isopropyl myristate or isopropyl palmitate as synergist with plant essential oils, demonstrating rapid knockdown with minimal mammalian toxicity (oral LD50 >10,000 mg/kg). |
| BEIERSDORF AG | Cosmetic and dermatological emulsion products requiring viscosity control, including leave-on formulations (up to 20% IPP) and rinse-off products (up to 45% IPP) with enhanced skin feel and emollient properties. | Cosmetic Emulsion Preparations | Isopropyl palmitate functions as viscosity-regulating agent in emulsion formulations without requiring additional thickeners or gelling agents, simplifying formulation complexity while maintaining desired rheological properties. |
| POLYMER SOLVENTS INC. | Industrial cleaning applications requiring effective solvent carriers with reduced occupational health hazards, particularly in enclosed spaces where inhalation exposure control is critical. | Reduced Toxicity Cleaning Agents | Production process reduces isopropyl bromide (2-bromopropane) content in cleaning formulations, lowering inhalation toxicity risks while maintaining soil removal efficacy, contrasting with 2-bromopropane's reproductive and neurotoxic effects at >1 ppm chronic exposure. |